Webinar: Early-Stage Venture Capital Investment Opportunities in a Post-COVID World

News May 29, 2020 Samsung Catalyst Fund Team

To register, please click here.


Acting as a catalyst for change, the COVID-19 pandemic has shed light on the contemporary direction of business development and pinpointed key industries for VC investors. Whilst the move towards embracing the 4th Industrial Revolution is no new concept, in the wake of the outbreak, companies are truly uncovering and appreciating the opportunities that accompany digital transformation.

Navigating through the new landscape, BGV’s Eric Benhamou and Samsung Catalyst Fund’s Shankar Chandran will dissect how the recent COVID-19 shock has impacted venture-backed companies and venture firms. Additionally, the pair will delve into capital allocation strategy and share insights on how to capitalize on this new wave of business metamorphosis and a new generation of “Enterprise 4.0” startups.

Join the webinar for a fireside chat with Benhamou Global Ventures (BGV) and Samsung, as they discuss how to leverage early stage venture capital opportunities, post-COVID. Taking factors such as scalability and spike capacity into account, Eric and Shanker will reveal the key to identifying startups and projects that marry shock-resistance with the needs of the modern business age.


Webinar Agenda Includes:

  • Highlight what VC investors can learn from the recent COVID-19 pandemic
  • Reveal how BGV and Samsung will reposition their investment strategies post-COVID
  • Compare forecasted returns for VC funds of vintage 2020-21 with vintages 2018-19
  • Uncover how investors can take advantage of post-COVID early-stage opportunities
  • Which aspects should be covered as part of each policy? Assessing business opportunities for underwriting in these emerging areas

To register, please click here.

 

Stay informed

At Samsung, we are passionate about fostering innovation and we'd love to keep in touch with you about the latest updates in artificial intelligence, mobility, digital health, and more. You may unsubscribe at any time.  For more information on our commitment to privacy, please see our privacy policy.